FATE THERAPEUTICS INC — Director's Dealing 2018

Aug 3, 2018

SEC Form 4/A — Form 4/A

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2018-07-18

Reporting Person: Wolchko J Scott (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-18	Stock Option (right to buy)	$11.03	A	152000	Acquired	2028-07-17	Common Stock (152000)	Direct

Footnotes

F1: The number of shares reported on this amended Form 4 reflects the correct number of shares underlying the stock option granted to Mr. Wolchko on July 18, 2018.

F2: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on August 18, 2018 such that this option is fully exercisable on July 18, 2022.

F3: Not applicable.